EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.456
https://www.valueinhealthjournal.com/article/S1098-3015(23)00556-9/fulltext
Section Title :
Section Order :
11837
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00556-9&doi=10.1016/j.jval.2023.03.456